Plasmic score applicability for the diagnosis of thrombotic microangiopathy associated with ADAMTS13-acquired deficiency in a developing country
Hematol., Transfus. Cell Ther. (Impr.)
;
41(2): 119-124, Apr.-June 2019. tab, ilus
Artículo
en Inglés
| LILACS
| ID: biblio-1012174
ABSTRACT
ABSTRACT Background:
Thrombotic thrombocytopenic purpura (TTP) is a potentially fatal disease that requires early diagnosis and treatment that can be made possible by applying the PLASMIC score. This study aims to evaluate this score applicability for patients with suspected TTP in a developing country.Methods:
This was a retrospective study performed at a tertiary hospital in the northeastern region of Brazil. Patients were analyzed in two groups ADAMTS13 activity <10% and activity >10%. Patients were stratified according to the PLASMIC score, and the level of agreement between the PLASMIC score and the ADAMTS13 activity was evaluated.Results:
Eight patients with thrombotic microangiopathy were included. Four patients had ADAMTS13 activity <10%, all with a PLASMIC score =6. The other four had ADAMTS13 activity >10%, all with a score <6. Based on a score =6 for presumptive diagnosis of TTP, we attained a 100% diagnostic accuracy in our sample. The PLASMIC score was also able to accurately predict response to plasma exchange and the risk of long-term unfavorable outcomes.Conclusions:
The reproducibility of the PLASMIC score was quite satisfactory in our sample. It accurately discriminates between patients who had ADAMTS13 deficiency and those with normal enzyme activity, precluding the need for specific laboratory evaluation, which is not always available. This score can be useful for an early diagnosis and indicates which patients will benefit from the treatment in developing countries.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Púrpura Trombocitopénica Trombótica
/
Activador de Tejido Plasminógeno
/
Microangiopatías Trombóticas
/
Proteína ADAMTS13
Tipo de estudio:
Estudio diagnóstico
/
Estudio observacional
/
Estudio pronóstico
/
Factores de riesgo
/
Estudio de tamizaje
Límite:
Adolescente
/
Adulto
/
Femenino
/
Humanos
/
Masculino
/
Embarazo
Idioma:
Inglés
Revista:
Hematol., Transfus. Cell Ther. (Impr.)
Asunto de la revista:
Hematologia
/
TransfusÆo de Sangue
Año:
2019
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Centro de Hematologia e Hemoterapia do Ceará/BR
/
Hospital Geral Dr. César Cals/BR
/
Universidade de Fortaleza/BR
Similares
MEDLINE
...
LILACS
LIS